Safe Orthopaedics announces its 2019 results

                                                                                                                                                                                                 

Safe Orthopaedics announces its 2019 results

► Revenues for 2019 of 4,7 M€, up 38%
► Commercial growth for the fourth quarter of 2019, up 52%

• Operational and technological growth justifying an operating income lower than 1,3 M€ in 2018
• New technologies ready for launch in 2020
• Cash-flow of 1,2M€ at end of April

  

 Éragny-sur-Oise, France, April 28 2020, 18h30 CEST – Safe Orthopaedics (FR0013467123 - ALSAF), a company specialized in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures urgently treated, announces its 2019 results, describes its commercial and financial performances and its technological investments for the second semester.

The 2019 Annual Financial Report of Safe Orthopaedics will be available on the website of the Company (www.SafeOrthopaedics.com), under heading Investors > Documentation > Documents and publications, as from April 30 2020.

Major commercial investment in 2019

Thousands of euros – IFRS	31/12/2019	31/12/2018	Growth
Revenues – Direct sales	2 109	2 134	-1%
Revenues – Indirect sales	2 683	1 337	+101%
Total revenues	4 792	3 471	+38%
Cost of goods sold and inventory variation	(3 420)	(1 965)
External loads	(3 257)	(3 071)
Personnel expenses	(4 633)	(3 507)
Other operating charges	(939)	(807)
Recurring operating income	(7 456)	(5 877)
Other operating income and charges	8	(272)
Operating income	(7 449)	(6 150)
Financial result	-521	350
Net Income	(7 970)	(5 800)